Midodrine for low blood pressure on standing after spinal cord injury
Tests midodrine and other treatments for low blood pressure in people with spinal cord injury.
Key facts
- Who runs it
- James J. Peters Veterans Affairs Medical Center
- Where
- The Bronx and West Orange, United StatesSee the 2 sites
- Trial code
- Registry title
- Treatment of Orthostatic Hypotension in SCI
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 25 people, planned
- Started
- 1 Jul 2023
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Midodrine Hydrochloride
- Record updated
- 10 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a spinal cord injury caused by trauma who have low blood pressure. It tests midodrine, droxidopa and compression garments.
- Age
- 18 Years to 60 Years
- Sex
- All sexes can join.
- Disease stage
- Traumatic spinal cord injury at level C1-T6, AIS grade A, B or C, at least 12 months after the injury. People must be unable to walk and must not need a breathing machine (ventilator).
Main reasons for not taking part
- Active mental health disorder, Alzheimer's disease or dementia
- Stroke, brain blood vessel disease, or another nerve disease besides the spinal cord injury
- Uncontrolled heart rhythm problems
- Body-wide, liver or kidney disease, or known or suspected cancer
- Self-reported 3 or more episodes of autonomic dysreflexia (sudden blood pressure spikes) per day
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- traumatic spinal cord injury
- at least 12 months post injury
- injury level of C1-T6
- AIS A, B or C
- non-ambulatory
- non-ventilator
Who cannot take part
- Concurrent systemic, hepatic, or renal disease
- Active psychiatric disorder
- Stroke or cerebrovascular disease
- Alzheimer's Disease or dementia
- Unmanaged cardiac arrhythmias
- Suspected or diagnosed malignancy
- Neurological disease other than SCI
- Self-reported history of three or more symptomatic episodes of AD per day
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 60 years old?
Where in United States
- James J Peters VA Medical CenterThe Bronx, United StatesContact: Dylan C Arnero, MATaking people
- Kessler FoundationWest Orange, United StatesContact: Matthew T Maher, MSTaking people
About the trial
What the trial wants to find out
The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals with SCI.
The 2 groups in the trial
- Study 1Treatment being tested
Twenty-five participants will be asked to visit the laboratory on 6 occasions, for an open-label, dose escalation trial to determine the effect of midodrine and droxidopa on supine and seated blood pressure and on symptoms of autonomic dysreflexia and orthostatic hypotension.
Treatment: Midodrine Hydrochloride
- Study 2Treatment being tested
Determine the effects of compression garments, midodrine, and droxidopa, compared to placebo, on orthostatic hemodynamics, symptoms of AD and OH and reporting of fatigue and thermal comfort.
Treatment: Midodrine Hydrochloride
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Treatment of Orthostatic Hypotension in Individuals With Spinal Cord Injury
- Plain-language title
- Midodrine for low blood pressure on standing after spinal cord injuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05839652, who can take part
- Record updated
- 10 August 2026